Menu
iCAN is collaborating with startups to create opportunities for growth
iCAN is a cutting-edge precision cancer medicine and digital health initiative. Startups collaborating with iCAN get unprecedented access to Finland’s rich clinical data, the opportunity to test in real-world settings,…
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill and iCAN, the Finnish national cancer research flagship project, signed a partnership aiming to improve the detection of trace tumour DNA from thousands of biobank samples. Genomill, a pioneering…
Exciting R2B funding news
iCAN had a strong showing in Business Finland’s last Research to Business funding round. Four out of eight projects funded at the University of Helsinki were from the iCAN community,…